Galatenko AV - Search Results

1

Highly informative marker sets consisting of genes with low individual degree of differential expression.

Galatenko VV, Shkurnikov MY, Samatov TR, Galatenko AV, Mityakina IA, Kaprin AD, Schumacher U, Tonevitsky AG. Galatenko VV, et al. Among authors: galatenko av. Sci Rep. 2015 Oct 8;5:14967. doi: 10.1038/srep14967. Sci Rep. 2015. PMID: 26446398 Free PMC article.

2

miRGTF-net: Integrative miRNA-gene-TF network analysis reveals key drivers of breast cancer recurrence.

Nersisyan S, Galatenko A, Galatenko V, Shkurnikov M, Tonevitsky A. Nersisyan S, et al. PLoS One. 2021 Apr 14;16(4):e0249424. doi: 10.1371/journal.pone.0249424. eCollection 2021. PLoS One. 2021. PMID: 33852600 Free PMC article.

3

Low expression of CD24 is associated with poor survival in colorectal cancer.

Nersisyan S, Ahlers AK, Lange T, Wicklein D, Galatenko A, Bohnenberger H, Elakad O, Conradi LC, Genduso S, Maar H, Schiecke A, Maltseva D, Raygorodskaya M, Makarova J, Schumacher U, Tonevitsky A. Nersisyan S, et al. Biochimie. 2022 Jan;192:91-101. doi: 10.1016/j.biochi.2021.10.004. Epub 2021 Oct 9. Biochimie. 2022. PMID: 34637894

4

Changes in the Level of Circulating hsa-miR-297 and hsa-miR-19b-3p miRNA Are Associated with Generalization of Prostate Cancer.

Osip'yants AI, Knyazev EN, Galatenko AV, Nyushko KM, Galatenko VV, Shkurnikov MY, Alekseev BY. Osip'yants AI, et al. Among authors: galatenko av. Bull Exp Biol Med. 2017 Jan;162(3):379-382. doi: 10.1007/s10517-017-3620-6. Epub 2017 Jan 14. Bull Exp Biol Med. 2017. PMID: 28091918

5

Plasma Level of hsa-miR-619-5p microRNA Is Associated with Prostatic Cancer Dissemination beyond the Capsule.

Shkurnikov MY, Makarova YA, Knyazev EN, Fomicheva KA, Galatenko AV, Nyushko KM, Galatenko VV, Vechorko VI, Alekseev BY. Shkurnikov MY, et al. Among authors: galatenko av. Bull Exp Biol Med. 2017 Aug;163(4):475-477. doi: 10.1007/s10517-017-3831-x. Epub 2017 Aug 29. Bull Exp Biol Med. 2017. PMID: 28853076

6

Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19.

Shkurnikov M, Nersisyan S, Jankevic T, Galatenko A, Gordeev I, Vechorko V, Tonevitsky A. Shkurnikov M, et al. Front Immunol. 2021 Feb 23;12:641900. doi: 10.3389/fimmu.2021.641900. eCollection 2021. Front Immunol. 2021. PMID: 33732261 Free PMC article.

7

Hypoxia-Induced miR-148a Downregulation Contributes to Poor Survival in Colorectal Cancer.

Nersisyan S, Galatenko A, Chekova M, Tonevitsky A. Nersisyan S, et al. Front Genet. 2021 May 31;12:662468. doi: 10.3389/fgene.2021.662468. eCollection 2021. Front Genet. 2021. PMID: 34135940 Free PMC article.

8

ExhauFS: exhaustive search-based feature selection for classification and survival regression.

Nersisyan S, Novosad V, Galatenko A, Sokolov A, Bokov G, Konovalov A, Alekseev D, Tonevitsky A. Nersisyan S, et al. PeerJ. 2022 Mar 30;10:e13200. doi: 10.7717/peerj.13200. eCollection 2022. PeerJ. 2022. PMID: 35378930 Free PMC article.

9

Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules.

Nersisyan S, Zhiyanov A, Zakharova M, Ishina I, Kurbatskaia I, Mamedov A, Galatenko A, Shkurnikov M, Gabibov A, Tonevitsky A. Nersisyan S, et al. PeerJ. 2022 Apr 27;10:e13354. doi: 10.7717/peerj.13354. eCollection 2022. PeerJ. 2022. PMID: 35502206 Free PMC article.

10

Cumulative prognostic power of laminin genes in colorectal cancer.

Galatenko VV, Maltseva DV, Galatenko AV, Rodin S, Tonevitsky AG. Galatenko VV, et al. Among authors: galatenko av. BMC Med Genomics. 2018 Feb 13;11(Suppl 1):9. doi: 10.1186/s12920-018-0332-3. BMC Med Genomics. 2018. PMID: 29504916 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters